Debevoise & Plimpton LLP is advising Clayton, Dubilier & Rice in its acquisition, together with TowerBrook Capital Partners, of R1 RCM Inc. (NASDAQ: RCM) (“R1”), at an enterprise value of $8.9 billion. For more information, please see the company’s press release.

R1 is a provider of technology-driven solutions that impact the patient experience and financial performance of healthcare providers.

The Debevoise team is led by M&A partners Kevin Rinker, Katherine Durnan Taylor and Christopher Anthony and includes partner William Regner, counsel Sergio Torres and Kim Le, associates Alexander Altieri, Julu Katticaran, Hannah Levine and Elina Sigal and law clerk Devon Donohue, finance partners Brett Novick and Scott Selinger and associates Marta Poplawski, Matthew Tolson and Jonathon Yeung, investment management senior corporate transactions manager James Titone, employee benefits and executive compensation partner Simone Hicks and associates Sandy De Sousa and Samuel Siegel, tax partner Michael Bolotin and associates Lauren Lin and Robert Nelson-Sullivan, capital markets partner Morgan Hayes and associate Maayan Stein, IP and technology transactions counsel Caroline Geiger and associate Mathew Anekstein, antitrust partners Tim Cornell and Timothy McIver and counsel Kyra Bromley, and litigation partner Maeve O'Connor, counsel Erich Grosz and associates Adam Aukland-Peck and Gabriel Kohan.